{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-337953","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2026-08-06T20:05:28+00:00","discovered_at":"2026-08-06T20:07:10.269219+00:00","generated_at":"2026-08-06T20:08:01.272436+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Outset Medical Q2 revenue $31.6M (+1% YoY); signs $40M HCA refresh deal","bullets":["Net revenue $31.6M, up 1% YoY and 14% sequentially; recurring revenue $22.1M flat.","Gross margin 42% (+400 bps YoY); net loss $18.0M vs $18.5M prior year.","Signed three-year, $40M agreement with HCA Healthcare to refresh Tablo fleet.","Cash position $151M; net cash used $9.5M in quarter.","Reiterated FY2026 revenue guidance $125M-$130M (5-9% growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-337953","json":"https://secwatch.observer/filing/0001193125-26-337953.json","markdown":"https://secwatch.observer/filing/0001193125-26-337953.md","text":"https://secwatch.observer/filing/0001193125-26-337953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/0001193125-26-337953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/om-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:08:01.272436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}